HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Precursor-T lymphoblastic lymphoma after unrelated bone marrow transplantation in a patient with Fanconi anemia.

Abstract
Lymphoid malignancies are rare in patients with Fanconi anemia (FA), particularly after bone marrow transplantation. A boy, who was diagnosed with FA at the age of 5; underwent successful bone marrow transplantation at the age of 11. One year later, he presented with fever and dry cough, and was found to have an anterior mediastinal tumor. Biopsy of the tumor revealed precursor-T cell lymphoblastic lymphoma. Human leukocyte antigen analysis confirmed that the tumor cells were derived from the patient's own cells. He received mild chemotherapy for lymphoma, but his condition deteriorated rapidly and he died from excessive chemotherapy-related toxicity. The literature contains no reports of successful chemotherapy for lymphoid tumors in patients with FA, and therefore, alternatives to chemotherapy should be considered in the treatment of such patients.
AuthorsDaisuke Suzuki, Ryoji Kobayashi, Kazue Yasuda, Atsuko Nakagawa, Tsuyoshi Morimoto, Miharu Yabe, Hiromasa Yabe, Kunihiko Kobayashi
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 33 Issue 1 Pg. 22-4 (Jan 2011) ISSN: 1536-3678 [Electronic] United States
PMID21178706 (Publication Type: Case Reports, Journal Article)
Topics
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Bone Marrow Transplantation (adverse effects)
  • Child, Preschool
  • Fanconi Anemia (therapy)
  • Fatal Outcome
  • Humans
  • Male
  • Precancerous Conditions (complications, diagnosis, therapy)
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (complications, diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: